News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celgene Corporation (CELG) and Abraxis BioScience, Inc. Announce Shareholder Vote in Favor of Merger


10/14/2010 7:57:35 AM

SUMMIT, N.J. & LOS ANGELES--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) and Abraxis Bioscience, Inc. (NASDAQ: ABII) today announced that Abraxis’ shareholders approved the merger agreement between the companies. The companies anticipate the closing of the transaction will occur on October 15, 2010.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES